Alimera Sciences EBITDA margin
What is the EBITDA margin of Alimera Sciences?
The EBITDA margin of Alimera Sciences Inc. is -4.84%
What is the definition of EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin of companies in the Health Care sector on NASDAQ compared to Alimera Sciences
What does Alimera Sciences do?
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
Companies with ebitda margin similar to Alimera Sciences
- Tz has EBITDA margin of -4.89%
- Docebo has EBITDA margin of -4.89%
- Docebo has EBITDA margin of -4.89%
- Gujarat Apollo Industries has EBITDA margin of -4.88%
- Wix.com Ltd has EBITDA margin of -4.88%
- Luby`s has EBITDA margin of -4.85%
- Alimera Sciences has EBITDA margin of -4.84%
- Cibox Inter@ctive has EBITDA margin of -4.84%
- Radware has EBITDA margin of -4.83%
- Biotest AG has EBITDA margin of -4.83%
- Hummingbird Resources Plc has EBITDA margin of -4.83%
- A.H. Belo Corp has EBITDA margin of -4.83%
- Oldfields has EBITDA margin of -4.82%